Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

medical Oncology-2019

About Conference


Conference Series llc LTD invites all the participants from all over the world to attend 2nd World Conference on " Medical Oncology & Haematology ” during March 27- 28, 2019 in Hongkong. The conference will be organized around the theme “An Elightenment in the Arena of Medical Oncology”

 

Why to attend?

With members from around the world focused on learning about  Medical Oncology & Haematology; this is your best opportunity to reach the largest assemblage of participants from the Cancer community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new developments and research, and receive name recognition at this event. World-renowned speakers, the most recent techniques, developments, and the newest updates in  Medical Oncology & Haematology , treatment and surgery involved are hallmarks of this conference.

Medical Oncology & Haematology 2019 welcomes Medical Oncologist, Chemotherapist , immunologists, pathologists, haematologists, oncologists, research scholars, industrial professionals and student delegates from biomedical and healthcare sectors to be a part of it.

Target Audience:

  •  Business Entrepreneurs Public
  •  Health Professionals
  •  Drug Manufacturing Companies
  •  Radiation Therapist
  •  Oncology Societies
  •  Clinical Researchers
  •  Leading world Doctors
  •  Surgical and Medical Hematologist
  • Young Researchers
  • Students & Delegates

Conference Highlights

  • Oncology & Its Subdivision
  • Medical Oncology
  • Therapies Involved in Medical Oncology
  • Clinical Trials In Medical Oncology
  • Haematology & Blood Disorder
  • Haematologic- Oncology
  • New Research in Blood Groups 
  • Cancer subtypes & their Treatments
  • Alternative Medicines
  • Nursing Oncology
  • Cancer Genetics
  • Biomarkers

Market Analysis

Summary

Medical Oncology is a methodology of treatment in cancer care which involves Chemotherapy, Immunotherapy, Hormonal Therapy and Targeted Therapy to treat cancer in a viable way. Medical Oncology is generally works in conjunction with Surgical Oncology or Radiation Oncology to give the best clinical results.

Hematology is the branch of medicine concerned with the study, diagnosis, treatment, and prevention of diseases related to blood. It involves treating diseases that affect the production of blood and its components such as blood cells, haemoglobin, blood proteins, bone marrow, platelets, blood vessels, spleen, and the mechanism of coagulation. A blood cell disorder is a condition in which there’s a problem with your red blood cells, white blood cells, or the smaller, circulating cells called platelets, which are critical for clot formation. All three cell types form in the bone marrow, which is the soft tissue inside your bones.

The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Medical Oncology & Haematology 2019, where you will be sure to have a meaningful experience with scholars from around the world.

Importance & scope

Medical Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A medical professional who practices  Medical oncology is an  Medical oncologist.Medical Oncology (MO) conveys the effects of clinical and test research in oncology and haematology, especially with trial therapeutics with the field of immunotherapy and chemotherapy. It additionally gives best in class surveys on clinical and test treatments in oncology and hematology. Topics include incorporate immunobiology, pathogenesis, and treatment of dangerous tumors.

Conference Series llc LTD  welcomes all the Medical Oncologists, Haematologists, Immunologists, Pathologists, Oncologists, Research scholars, Industrial Professionals and Student Delegates from Biomedical and healthcare sectors to be a part of the esteemed Blood Disorders 2019. Advanced Diagnostic and therapeutic equipment  along with the novel drugs for  the cancer & Blood diseases are an integral part of the Oncology & Hematology research, hence it will be an excellent amalgamation of academia and industry as it involves  every aspects of empirical and conceptual thinking  in exploring new dimensions in this field.  It is open to all types of research methodologies both from academia and industry.

Why Hong kong ?  

 Hong kong is considered as an important centre for higher education and harbours, healthcare, well reputed and prestigious colleges and Universities. It can be considered as a suitable medium for the relocation of valuable knowledge about research and novel advancements worldwide. The conferences taking part here would promote a variety of scientific ideas among contenders belonging to diverse areas of science and technology. Cancer patients in Hong Kong will receive more advanced and timely treatments once the city’s first cancer centre begins operations in eight years, the head of the billion-dollar project has said . Hong kong excels in the five-year survival rates of colon cancer, lung cancer, pancreatic cancer and liver cancer based on the comparison of a report by the American Association of Oncology and another report by the Hong Kong Foundation for the Promotion of Cancer research. The same comparison shows that the US excels in the five-year survival of rectal cancer, breast cancer, prostate cancer and malignant lymphoma. Surgical outcomes tend to be better in Hong kong for most cancers while overall survival tend to be longer in the US due to the more aggressive use of chemotherapy in late stage cancers. 

Cancer Universities Worldwide

  • University of Oxford
  • University of Cambridge
  • UCL London's Global University
  • Stanford University
  • Western University
  • University of Nottingham
  • University of Bologna
  • University of Athens
  • University of Chicago
  • University of Washington
  • University of Rochester
  • The University of Melbourne
  • University of Glasgow
  • Fudan University
  • Stanford University
  • University of Minnesota
  • University of Albert
  • University of Nebraska
  • University of Iowa Carver
  • University of Pennsylvania
  • South-western University
  • University of Pittsburgh
  • University of Helsinki
  • University of Penn Medicine

  Universities in Asia

  • Osaka University
  • Tsinghua University
  • Fudan University
  • Taipei Medical University
  • KAIST - Korea Advanced Institute of Science and Technology
  • Yonsei University
  • Shanghai Jiao Tong University
  • Nanyang Technological University (NTU)
  • Chulalongkorn Universit
  • Tohoku University
  • Tokyo Medical and Dental University
  • Kyushu University
  • Nagoya University
  • Hokkaido University
  • Sungkyunkwan Universit
  •  Indian Institute of Science
  • University Kebangsaan Malaysia (UKM)
  • University Saints Malaysia (USM)
  • Beijing University of Chinese Medicine
  • National Tsing Hua University

    Associations Worldwide

  • Life South Community Blood Centre
  • World congress of the International society of Hematology
  • International society of Hematology
  • World federation of Haemophilia
  • European Hematology Associations
  • Malaysian society of Hematology
  • Armenian associations of Hematology & Oncology
  • Japanese society of Hematology
  • Japan Primary Care Association

  Association in Asia Pacific

  • The Asia-Pacific Urogynecology Association
  • The Asia-Pacific Cancer Society Training
  • Asian Cancer Foundation India
  • The Max Foundation
  • Childhood Cancer International Netherlands
  • The Asia Pacific Prostate Society

 Cancer hospitals worldwide

  •  Leiden University Medical Centre
  • Royal Cancer Hospital
  • King’s College Hospital
  • Clatter bridge Centre for Oncology
  • Northampton General Hospital
  • Cambridge University Hospitals
  • University Hospital Southampton
  • Central Manchester University Hospitals

Sessions/ Tracks

Track 1: Oncology & Its subdivision:

The term oncology actually implies a branch of science that arrangements with tumors and growths. "Onco" implies mass, mass, or tumor while "- logy" means ponder.Basically Oncology is the study which deals with the prevention, diagnosis, and treatment of cancer.
The three segments which have enhanced survival in tumor are:

Prevention – by reducing of cancer causing factors like tobacco and liquor consumption.
Early Identification – screening of basic cancers and far reaching diagnosis and Staging
Treatment – by talk in tumor board and treatment in a comprehensive cancer centre.

Subdivisions:
Medical Oncology: It Involve chemotherapy, hormone therapy, and other drugs to treat cancer.
Radiation Oncology: It Involve the use of radiations to treat cancer.
Surgical Oncology: It Involve the use of surgery and other procedures to treat cancer.

Track 2: Medical Oncology:

It Involve chemotherapy, hormone treatment, and different medications to treat cancer.A specialist who has training  in identification and treating cancer in adults utilizing chemotherapy, hormonal treatment, Immuno treatment, and targeted treatment. A medical oncologist often is the primary health care provider for somebody who has malignancy. Essentially Medical Oncology is one of the sub-division of Oncology branch, and it includes the treatment of most of the malignancies by utilizing its applications.

Track 3: Therapies Involved in Medical Oncology:

Chemotherapy :
Chemotherapy frequently contracted to chemo and sometimes CTx is a class of malignancy treatment that utilizes at least one or more cancer drugs i.e.; chemotherapeutic agents as a major aspect of an standardized chemotherapy regimen. Chemotherapy might be given with a remedial purpose which quite often includes combination of medications, or it might intend to prolong life or to reduce indications palliative chemotherapy. Chemotherapy is one of the real classifications of the medical discipline particularly committed to pharmacotherapy for malignancy, which is called medical oncology.

Hormonal therapy:
It includes the control of the endocrine system through exogenous or external intake of particular hormones, especially steroid hormones, or medications which restrain the action of hormones. Hormonal therapy is utilized for a few kinds of diseases got from hormonally responsive tissues, including the breast, prostate, endometrium, and adrenal cortex. Hormonal therapy may also be utilized as a part of the treatment of chemotherapy-related symptoms, for example, anorexia.

Immunotherapy
Immunotherapy is the "treatment of disease by inciting, upgrading, or supressing an immune  response" Immunotherapies intended to inspire or increase an invulnerable reaction are named initiation immunotherapies, while immunotherapies that diminish or stifle are knowns as supression immunotherapies.

Biological Therapy:
Biological treatment incorporates the use of living animals, substances got from living structures, or research focus conveyed variations of such substances to treat cancer. Some bilogical medications for tumor engage the body's immune rsponse to act against cancer cells.

Targeted therapy:
Targeted therapy is a malignancy treatment that utilizations drugs. It is not the same as conventional chemotherapy. The drugs known as focused treatment help prevent malignancy from developing and spreading. They work by focusing on particular genes or proteins.

Radiation therapy:
Radiation therapy regularly known as RT, and it is a treatment utilizing ionizing radiation, commonly as a major aspect of tumor treatment to control or execute harmful cells and ordinarily conveyed by a linear accelerator. Radiation therapy might be corrective in various type of cancer if they are localized to one part of the body.

Track 4: Clinical Trials In Medical Oncology:

Clinical trials look at new cancer medicines through patient-based research. They give the basic information to decide whether new medications are protected and powerful. An extensive variety of treatments are contemplated in clinical trials going from drugs through to radiological and careful techniques, and additionally precaution alternatives to prevent cancer. Clinical trials are fundamental for the progression of oncological learning and the change in quality of life for cancer patients. The Medical Oncology Group of Australia is focused on supporting clinical trials.

Track 5: Haematology & Blood Disorder:

Iron deficiency is the most well-known sort of blood issue we treat. Patients with anaemia have an insufficiency of oxygen-rich red platelets or their red platelets don't work appropriately. A low level of hemoglobin, the iron-rich protein that conveys the oxygen in red platelets, flags the condition. Anaemia can be constant, or a brief condition caused by other medical problems, including growth treatment, hepatitis C, and HIV/AIDS. Anemia every now and again stays undiscovered in light of the fact that it is a fundamental state of other medical problems, including growth, cardiovascular malady, diabetes, HIV/AIDS, fiery entrail sickness, unending kidney infection, and rheumatoid joint pain. Hemophilia is a rare typicall inherited blood disorder, commonly acquired blood issue in which the blood does not appropriately clump and causeintemprate dying, which can make harm organs, joints, and tissues. Patient may experience the ill effects of the site of damage or from inward dying. Coagulating Disorders Hematologists likewise treat conditions identified with the proteins that trigger draining and thickening, including thrombosis (thickening) and hemostasis (dying). Thrombosis refers to the formation of abnormal blood clots that become embedded in a major vein or artery, blocking blood circulation. Blood clots can cause pain, swelling, or warmth in the affected area, and can be life-threatening. Hemostasis is the process of controlling bleeding. Blood Cancers Cancerous blood conditions include leukemia, Hodgkin lymphoma, non-Hodgkin lymphoma, and multiple myeloma.

Track 6: Haematologic- Oncology:

Hematologic Oncology is the branch of medicine study about the diagnosis ,prevention, treatment, and avoidance of disease identified with blood. Hematology incorporates the study of etiologist includes treating disease that influence the production of blood and its parts, for example, platelets, hemoglobin, blood proteins, bone marrow, platelets, veins, spleen, and the component of coagulation. The research facility work that goes into the study of blood is much of the time performed by a medical technologist or therapeutic lab researcher. Hematologists also conduct study in oncology and work with oncologists, individuals who may specialize just in that field rather than both-the therapeutic treatment of tumor. There are different disorders that people are influenced by hematology. A couple of these different type of blood conditions that are looked at incorporate anaemia, hemophilia, general blood clots, bleeding disorders, and so forth. With respect to related blood diseases, for example, leukemia, myeloma, and lymphoma, these are more serious cases that should be analysed.

Track 7: New Research in Blood Groups :

Langereis Blood Group or Junior blood typeIt is exceptionally lesser known blood group yet it could be a matter of life and death. A recent research In the February issue of Nature Genetics, Ballif and his partners give an account of their disclosure of two proteins on red platelets in charge of these lesser-known blood groups.
Ballif distinguished the two molecules as specific transport proteins ie; ABCB6 and ABCG2. "Just 30 proteins have beforehand been distinguished as in charge of a basic blood type," Ballif notes, "however the counting number currently comes to 32." The last new blood group   proteins to be found were about 10 years back, Ballif says, "so it's entirely noteworthy to have two distinguished this year." Both of the recently recognized proteins are additionally connected with anticancer drug opposition, so the discoveries may likewise have suggestions for enhanced treatment of breast and different cancers.

Track 8: Cancer subtypes & their Treatments:

There are many types of cancer. Some of them are given below:

‚ÄčThe kinds of treatment that you get will rely upon the type ofcancer you have and how best in class it is.A few people with cancer will have just a single treatment. However, many people have a mix of treatments, for example, medical procedure with chemotherapy and additionally radiation treatment.

Track 9: Alternative Medicines:

Ayurvedic drug is an old Indian system of medication which started around 5,000 years prior. It is not only one treatment. It is a method for diagnosing disease and utilizing an extensive variety of medications and strategies. Home grown medication utilizes plants, or blends of plant mixture, to treat disease and promote health. It intends to restore your body's capacity to secure, manage and heal itself. It is an entire body approach, so look   at your physical, mental and emotional well-being. It is now and again called phytomedicine, phytotherapy or natural pharmaceutical. Naturopathic specialists (NDs) trust that cancer emerges from an imbalance that causes a systemic breakdown inside the body. Homeopathy depends on the hypothesis of treating like with like. So to treat a sickness a homeopathic specialist (homeopath) utilizes minor dose of a substance that in large dosages would actually cause the symptom of the illness.

Track 10: Cancer Nursing: 

An oncology nurse is a selected nurture who takes care of and shows patients who have tumour. Oncology specialists work in a multi-disciplinary gathering, in a combination of settings, from the inpatient ward, where it counts marrow transplant unit, through to the group. They may work with a variety of patients, from children to the elderly, from outpatients through to palliative care.

Track 11: Cancer Genetics:

cancer is a hereditary disease and sometime it is caused by specific changes to genes which are responsible to control the way of our cells function, particularly how they grow and separate.
Genes convey the guidelines to make proteins, which do a significant part of the work in our cells. Certain gene changes can make cells dodge typical development controls and move toward becoming cancer. For instance, some cancer causing gene changes increment generation of a protein that influences cells to develop. Others result in the generation of a deformed, and in this manner non-functional, type of a protein that regularly repairs cell harm.

Track 12: Biomarkers:

Protein Biomarkers can be used as biomarkers for early recognition of cancer particularly used for the identification of breast cancer. Diagnostic Patients with suspected pancreatic cancer will experience an underlying CT scan to decide if a suspect mass is localized and removed by surgery 63% of patients will be diagnosed with non-respectable stage III and IV disease and a biopsy will be attempted to confirm pancreatic tumour by H&E pathological assay. The presence of cancerous cells by means of pathology is very challenging because of high quantities of non-cancerous stromal infiltrating cells and administration of chemotherapy or enrolment into a clinical trial will just initiate on definitive diagnosis of pancreatic cancer. These will see particularly stains neoplastic pancreatic cells would empower the pathologist to confidently diagnose pancreatic cancer and in this way offer appropriate cancer treatment to the patients. The Novel Biomarker BI-010 has been recognized as a highly sensitive (98%) and particular (95%) IHC marker for pancreatic cancer and CRT is looking for a partner to build up an IHC based test to distinguish BI-010 in fine needle suction biopsies from biopsy tests.

Track 13: Cancer Cell Biology:

The hereditary changes that add to malignancy tend to influence three primary sorts of qualities - proto oncogenes, tumor supressor gene, and DNA repair genes. These progressions are some of the time called "drivers" of growth. Proto-oncogenes are associated with typical cell development and division. Be that as it may, when these genes are altered in certain ways or are more active than ordinary, they may move toward becoming malignancy causing genes (or oncogenes) enabling cells to develop and survive when they should not. Tumor supressor genes are additionally engaged with controlling cell development and division. Cells with specific changes in tumor supressor ggenes may separate in an uncontrolled way. DNA repair qualities are associated with settling harmed DNA. Cells with changes in these genes have a tendency to build up extra transformations in different qualities. Together, these changes may make the cells end up dangerous. The procedure by which tumor cells spread to different parts of the body is called metastasis. Metastatic tumor spreads from the piece of the body where it began (the essential site) to different parts of the body. 
 

 


 

 


 


 


 


 

Exhibition Content

The 2nd World Conference on Haematology & Medical Oncology will exhibit the products and services from commercial and non-commercial organizations like Drug manufactures, Clinical Trial Sites, Management Consultants, Chemists, Pharmacists, Business delegates and Equipment Manufacturers.

To Collaborate Scientific Professionals around the World

Conference Date Mar 27-28, 2019

Speaker Opportunity

Supported By

Journal of Cancer Science & Therapy Chemotherapy: Open Access Journal of Integrative Oncology Advances in Oncology Research and Treatments

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

Collaboration

Collaboration